The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Osteoarthritis Therapeutics Market Report by Anatomy Type (Knee, Hip, Hand, Spine, and Others), Drug Type (Nonsteroidal Anti-Inflammatory Drugs, Analgesics, Corticosteroids, and Others), Route of Administration (Parenteral, Topical, Oral), Distribution Channel (Hospitals, Specialty Clinics, Medical Institutions, and Others), and Region 2025-2033
US$ 3,999.00
The global osteoarthritis therapeutics market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.3 Billion by 2033, exhibiting a growth rate (CAGR) o...
August 2025
150 pages
Gastrointestinal Therapeutics Market Report by Type (Branded, Generic), Route of Administration (Oral, Intravenous, and Others), Application (Ulcerative Colitis, Crohn's Disease, GERD, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
US$ 3,999.00
The global gastrointestinal therapeutics market size reached USD 48.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 71.8 Billion by 2033, exhibiting a growth rate (CAGR...
August 2025
149 pages
Osteoporosis Drugs Market Report by Product Type (Bisphosphonates, Calcitonin, Rank Ligand Inhibitor, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, and Others), Route of Administration (Oral, Injectable, and Others), and Region 2025-2033
US$ 3,999.00
The global osteoporosis drugs market size reached USD 17.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.98%...
August 2025
148 pages
Herb Extract Market By Application (Pharmaceutical, Nutraceutical and Dietary Supplement, Cosmetics and Personal Care, Others), By Type (Turmeric or Curcuma Longa Linn, Ginger or Zingiber Officinale Roscoe, Indian Pennywort or Centella Asiatica, Aloe or Aloe Vera L.Burm.f., Fah Talai Jone or Andrographis Paniculata, Indian Gooseberry or Phyllanthus emblica L., Krachai Dum or Kaempferia Parviflora, Krathom or Mitragyna Speciosa, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
US$ 2,655.00
The herb extract market was valued at $8,189.71 million in 2023 and is estimated to reach $23,772.13 million by 2035, exhibiting a CAGR of 9.27% from 2024 to 2035. Herb extracts are concentrated prepa...
August 2025
311 pages
Psoriatic Arthritis Treatment Market Size, Share & Trends Analysis Report By Drug Class (NSAIDs, DMARDs, Biologics), By Type (Prescriptions, OTC), By Route Of Administration (Topical, Oral, Injectable), By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Psoriatic Arthritis Treatment Market The global psoriatic arthritis market size was estimated at USD 11.35 billion in 2024 and is p...
July 2025
110 pages
Analgesics Market - 2024-2032
US$ 2,999.00
The Analgesics Market was valued at US$ 56.02 billion in 2024 and is anticipated to reach US$ 80.50 billion by 2032, at a CAGR of 0.041 from 2026 to 2032. The report delivers in-depth insights into ke...
July 2025
218 pages
Enzyme Inhibitor Market - 2023-2032
US$ 2,999.00
The Enzyme Inhibitor Market was valued at US$ 182.77 billion in 2023 and is anticipated to reach US$ 256.53 billion by 2032, at a CAGR of 0.039 from 2026 to 2032. The report delivers in-depth insights...
July 2025
207 pages
U.S. Antibiotics Market Size, Share & Trends Analysis Report By Action Mechanism (Cell Wall, Protein, DNA, RNA), By Type (Branded Antibiotics, Generic Antibiotics), By Drug Class (Cephalosporins, Penicillin, Carbapenems), And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days U.S. Antibiotics Market The U.S. antibiotics market size was estimated at USD 13.77 billion in 2024 and is projected to reach USD 1...
July 2025
100 pages
Global Oxycodone Hydrochloride Market - 2024-2032
US$ 2,999.00
The Global Oxycodone Hydrochloride Market was valued at US$ 410 million in 2024 and is anticipated to reach US$ 503 million by 2032, at a CAGR of 0.09 from 2026 to 2032. The report delivers in-depth i...
July 2025
223 pages
Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Fluoroquinolone), By Type (Branded Antibiotics, Generic Antibiotics), By Action Mechanism, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global antibiotics market size is expected to reach USD 62.06 billion by 2025 expanding at a CAGR of 4.0%, according to a new ... . Government reforms specific to antibiotics, such as the Generating Antibiotics Incentives Now (GAIN) Act in U.S., are projected to help boost the market growth over the ...
July 2025
150 pages
Gastric Motility Disorder Drugs Market - 2024-2033
US$ 2,999.00
The Gastric Motility Disorder Drugs Market was valued at US$ 54.7 billion in 2024 and is anticipated to reach US$ 90.41 billion by 2033, at a CAGR of 0.05 from 2026 to 2032. The report delivers in-dep...
July 2025
223 pages
Botulinum Toxins Market by Product (Botox, Dysport, Jeuveau, Myobloc), Application (Cosmetic (Wrinkle Removal, Contouring, Skin rejuvenation), Therapeutic (OAB, Migraine, Spasm, Pain)), Volume, End User (Clinics, Center), Region - Global Forecast to 2030
US$ 4,950.00
The global botulinum toxins market is projected to reach USD 15.7 billion by 2030 from USD 8.9 billion in 2025, at a CAGR of 11.7% during the forecast period. The growth of the market can be attribute...
July 2025
236 pages
U.S. Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines), By Indication, By Dosage Form, By Distribution Channel, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days U.S. Antifungal Drugs Market The U.S. antifungal drugs market was estimated at USD 6.05 billion in 2024 and is projected to reach U...
July 2025
80 pages
U.S. Antibiotic Resistance Market Size, Share, & Trends Analysis Report By Disease (cUTI, CDI), By Pathogen, By Drug Class, By Mechanism of Action, By Distribution Channel, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days U.S. Antibiotic Resistance Market The U.S. antibiotic esistance market size was estimated at USD 3.09 billion in 2024 and is projec...
July 2025
80 pages
Advanced Drug Formulation Market Forecasts to 2032 – Global Analysis By Formulation Type (Oral, Injectable, Topical, Transdermal, Inhalation, Nasal, and Implantable), Drug Type, Therapeutic Area, Technology, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Advanced Drug Formulation Market is accounted for $1.9 trillion in 2025 and is expected to reach $2.9 trillion by 2032 growing at a CAGR of 6.1% during the for...
July 2025
200 pages
Oral Antibiotics Market Forecasts to 2032 – Global Analysis By Drug Class (Penicillins, Aminoglycosides, Cephalosporins, Sulfonamides, Macrolides, Fluoroquinolones, Tetracyclines, and Other Drug Classes), Spectrum of Activity, Indication, Patient Group, Distribution Channel, Formulation Type and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Oral Antibiotics Market is accounted for $51.40 billion in 2025 and is expected to reach $83.09 billion by 2032 growing at a CAGR of 7.1% during the forecast p...
July 2025
200 pages
Parenteral Antibiotics Market Forecasts to 2032 – Global Analysis By Drug Class (Penicillins, Macrolides, Cephalosporins, Glycopeptides, Carbapenems, Aminoglycosides, and Other Drug Classes), Spectrum of Activity, Formulation Type, Route of Administration, Indication, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Parenteral Antibiotics Market is accounted for $25.74 billion in 2025 and is expected to reach $39.48 billion by 2032 growing at a CAGR of 6.3% during the fore...
July 2025
200 pages
U.S. Dupixent Market Size, Share & Trends Analysis Report By Indication (Atopic Dermatitis, Asthma, Chronic Rhinosinusitis with Nasal Polyps, Chronic Obstructive Pulmonary Disease, Bullous Pemphigoid), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days U.S. Dupixent Market The U.S. dupixent market size was estimated at USD 10.39 billion in 2024 and is projected to reach USD 16.82 b...
July 2025
150 pages
Prescription Drugs Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
US$ 4,450.00
According to our new research study on “Prescription Drugs Market Forecast to 2031 -Global Analysis - by Product Type, Drug Type, Route Of Administration, Therapeutic Area, And Distribution Channel,”...
July 2025
329 pages
Asia-Pacific Pain Management Drugs Market - 2024-2033
US$ 2,999.00
The Asia-Pacific Pain Management Drugs Market was valued at US$ 14,230.57 million in 2024 and is anticipated to reach US$ 31,304.67 million by 2033, at a CAGR of 0.092 from 2026 to 2032. The report de...
July 2025
223 pages
Weight loss therapeutics Market - 2024-2033
US$ 2,999.00
The Weight loss therapeutics Market was valued at US$ 3.92 Billion in 2024 and is anticipated to reach US$ 20.84 Billion by 2033, at a CAGR of 0.206 from 2026 to 2032. The report delivers in-depth ins...
July 2025
219 pages
Global Friedreich's Ataxia Market - 2024-2033
US$ 2,999.00
The Global Friedreich's Ataxia Market was valued at US$ 0.96 Billion in 2024 and is anticipated to reach US$ 2.86 Billion by 2033, at a CAGR of 0.129 from 2026 to 2032. The report delivers in-depth in...
July 2025
219 pages
